FIN STREET SEC(01476): Yin Guohong appointed as executive director
Financial Street Securities (01476) announced that Mr. Yin Guohong was appointed as the fifth... after approval from shareholders at the extraordinary general meeting.
FIN STREET SEC (01476) Announcement: Upon approval of the shareholders at the extraordinary general meeting, Mr. Yin Guohong has been appointed as an executive director of the fifth board of directors, Mr. Xie Xin has been appointed as a non-executive director of the fifth board of directors, and Mr. Qi Liang has been appointed as an independent non-executive director of the fifth board of directors. The terms of the above directors will be from the date of the extraordinary general meeting to the end of the term of the fifth board of directors.
Mr. Li Ye has resigned as a non-executive director of the fifth board of directors and as a member of the strategic and investment decision committee of the fifth board of directors, and Ms. Yang Qin has resigned as a non-executive director of the fifth board of directors, effective from the date of the extraordinary general meeting.
The company held a staff representative congress on November 25, 2025, and the appointment of Mr. Zhou Lijun as a staff representative director of the fifth board of directors (non-executive director) was approved at the meeting. His term will be from November 25, 2025, until the end of the term of the fifth board of directors.
At the thirty-fourth extraordinary meeting of the board of directors, the board agreed to appoint Ms. Yu Lei as the vice president and chief financial officer of the company. Her term will be from the date of approval at the thirty-fourth extraordinary meeting of the board of directors to the end of the term of the fifth board of directors. Mr. Yin Guohong, the CEO of the company, will no longer assume the responsibilities of the finance director from the date of the thirty-fourth extraordinary meeting of the board of directors.
Related Articles

KFM KINGDOM (03816) released its interim financial results, with a net profit attributable to shareholders of HKD 29.853 million, representing a year-on-year increase of 37.2%.

CHINA BAOLI TEC(00164) issues profit warning, expecting the mid-term loss to increase to approximately HK$14 million to HK$18 million compared to the same period last year.

CH BIOTECH SER (08037): The boron neutron therapy device successfully achieved its first beam output.
KFM KINGDOM (03816) released its interim financial results, with a net profit attributable to shareholders of HKD 29.853 million, representing a year-on-year increase of 37.2%.

CHINA BAOLI TEC(00164) issues profit warning, expecting the mid-term loss to increase to approximately HK$14 million to HK$18 million compared to the same period last year.

CH BIOTECH SER (08037): The boron neutron therapy device successfully achieved its first beam output.

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


